/ Home / Product Center / APIs / Others /

Vonaprazan Fumarate

Vonaprazan Fumarate
CAS
1260141-27-2
MF
C21H20FN3O6S
MW
461.4634032
Purity
98%
Solubility
insoluble in H2O; insoluble in EtOH; ≥18.9 mg/mL in DMSO
Appearance
solid
Storage Temp
Store at -20°C
Indication
Gastrointestinal ulcer
Description

Vonoprazan fumarate (Takecab®), discovered and developed by Takeda and Otsuka, was approved by the PMDA of Japan in December 2014, and is indicated for the treatment of gastric ulcer,